NO992296D0 - FremgangsmÕte for disubstituerte pyridiner - Google Patents

FremgangsmÕte for disubstituerte pyridiner

Info

Publication number
NO992296D0
NO992296D0 NO992296A NO992296A NO992296D0 NO 992296 D0 NO992296 D0 NO 992296D0 NO 992296 A NO992296 A NO 992296A NO 992296 A NO992296 A NO 992296A NO 992296 D0 NO992296 D0 NO 992296D0
Authority
NO
Norway
Prior art keywords
disubstituted pyridines
pyridines
disubstituted
Prior art date
Application number
NO992296A
Other languages
English (en)
Norwegian (no)
Other versions
NO992296L (no
Inventor
Keith Michael Devries
Robert Lee Dow
Stephen Wayne Wright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO992296L publication Critical patent/NO992296L/no
Publication of NO992296D0 publication Critical patent/NO992296D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO992296A 1996-11-14 1999-05-12 FremgangsmÕte for disubstituerte pyridiner NO992296D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3088096P 1996-11-14 1996-11-14
PCT/IB1997/001367 WO1998021184A1 (en) 1996-11-14 1997-11-03 Process for substituted pyridines

Publications (2)

Publication Number Publication Date
NO992296L NO992296L (no) 1999-05-12
NO992296D0 true NO992296D0 (no) 1999-05-12

Family

ID=21856496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992296A NO992296D0 (no) 1996-11-14 1999-05-12 FremgangsmÕte for disubstituerte pyridiner

Country Status (32)

Country Link
US (1) US6291489B1 (de)
EP (1) EP0938476B1 (de)
JP (1) JP3510635B2 (de)
KR (1) KR20000053314A (de)
CN (1) CN1237160A (de)
AP (1) AP805A (de)
AR (1) AR010584A1 (de)
AT (1) ATE319687T1 (de)
AU (1) AU4634697A (de)
BG (1) BG103393A (de)
BR (1) BR9712951A (de)
CA (1) CA2270386C (de)
CO (1) CO4930261A1 (de)
DE (1) DE69735433D1 (de)
EA (1) EA199900375A1 (de)
GT (1) GT199700118A (de)
HR (1) HRP970612A2 (de)
ID (1) ID18898A (de)
IL (1) IL129688A0 (de)
IS (1) IS5029A (de)
MA (1) MA24401A1 (de)
MY (1) MY132507A (de)
NO (1) NO992296D0 (de)
OA (1) OA11044A (de)
PA (1) PA8441401A1 (de)
PE (1) PE10299A1 (de)
TN (1) TNSN97172A1 (de)
TR (1) TR199901063T2 (de)
UY (1) UY24774A1 (de)
WO (1) WO1998021184A1 (de)
YU (1) YU22099A (de)
ZA (1) ZA9710186B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9909555A (pt) * 1998-04-08 2000-12-19 Novartis Ag Novartis S A Novar Herbicidas
US6090942A (en) * 1998-10-15 2000-07-18 Pfizer Inc. Process and intermediates for a β3 -adrenergic receptor agonist
KR20010102198A (ko) * 1999-02-16 2001-11-15 후루타 타케시 치환 아세틸피리딘 유도체 및 그를 이용하는 광학활성 β3작용제 중간체의 제조 방법
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
EP1078924B1 (de) * 1999-07-23 2004-10-20 Pfizer Products Inc. Zwischenprodukte und ein Verfahren zur Herstellung von beta3-Adrenergischer Rezeptor-Agoniste
JPWO2003033468A1 (ja) * 2001-10-17 2005-02-03 株式会社カネカ (S)−α−ハロメチルピリジンメタノール誘導体の製造方法
MXPA04008298A (es) 2002-02-27 2004-11-26 Pfizer Prod Inc Procesos e intermedios utiles en la preparacion de agonistas de receptor beta-3 adrenergico.
AU2003209527A1 (en) * 2002-02-27 2003-09-09 Pfizer Products Inc. Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
US6864268B2 (en) 2002-02-27 2005-03-08 Pfizer Inc. β3 adrenergic receptor agonists
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
KR100751163B1 (ko) 2003-05-09 2007-08-22 에프. 호프만-라 로슈 아게 알파-1 아드레날린 작용물질로서의 메틸 인돌 및 메틸피롤로피리딘
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US20110160249A1 (en) 2008-05-23 2011-06-30 Schaab Kevin Murray 5-lipoxygenase-activating protein inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
US5019578A (en) 1987-11-27 1991-05-28 Merck & Co., Inc. β-adrenergic agonists
BR9406823A (pt) 1993-06-14 1996-03-26 Pfizer Aminas secundárias e agentes anti-diabéticos e antiobesidade
IL113410A (en) 1994-04-26 1999-11-30 Merck & Co Inc Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
EP0828712A1 (de) 1995-05-10 1998-03-18 Pfizer Inc. Beta-adrenergische agonisten
JPH11504649A (ja) * 1995-05-10 1999-04-27 ファイザー・インコーポレーテッド β−アドレナリン作働性アゴニスト

Also Published As

Publication number Publication date
US6291489B1 (en) 2001-09-18
CA2270386A1 (en) 1998-05-22
CA2270386C (en) 2004-08-03
TNSN97172A1 (fr) 2005-03-15
AU4634697A (en) 1998-06-03
ID18898A (id) 1998-05-20
HRP970612A2 (en) 1998-08-31
CO4930261A1 (es) 2000-06-27
UY24774A1 (es) 1998-05-05
EP0938476A1 (de) 1999-09-01
YU22099A (sh) 2001-09-28
AP9701147A0 (en) 1998-01-31
JP3510635B2 (ja) 2004-03-29
TR199901063T2 (xx) 1999-08-23
CN1237160A (zh) 1999-12-01
BR9712951A (pt) 1999-12-07
ZA9710186B (en) 1999-05-12
MY132507A (en) 2007-10-31
PA8441401A1 (es) 2000-05-24
KR20000053314A (ko) 2000-08-25
NO992296L (no) 1999-05-12
PE10299A1 (es) 1999-02-10
ATE319687T1 (de) 2006-03-15
AR010584A1 (es) 2000-06-28
IS5029A (is) 1999-04-16
OA11044A (en) 2002-02-20
MA24401A1 (fr) 1998-07-01
AP805A (en) 2000-01-28
EP0938476B1 (de) 2006-03-08
DE69735433D1 (de) 2006-05-04
IL129688A0 (en) 2000-02-29
JP2000504347A (ja) 2000-04-11
WO1998021184A1 (en) 1998-05-22
GT199700118A (es) 1999-05-05
EA199900375A1 (ru) 1999-12-29
BG103393A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
NO990531D0 (no) Partikkel-siktanordning
DZ2261A1 (fr) Cyclo-alcane pyridines.
BR9708989A (pt) Piridil cetoenóis substituídos
DE69627112D1 (de) Bettvorrichtung
DE69621432D1 (de) Bettvorrichtung
DE69520558D1 (de) Halogenierungsverfahren
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
NO992296D0 (no) FremgangsmÕte for disubstituerte pyridiner
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
DE69703305D1 (de) System zum herstellen von polsterelementen
DE69708277D1 (de) Azeotroper destillationsprozess
IT1291359B1 (it) Procedimento per fabbricare pannelli truciolari
DE69507032D1 (de) Chlorhydrin-verfahren
DE69629942D1 (de) Herstellungsverfahren
DE69729051D1 (de) Bearbeitungsbetriebsmethode
NO20003079D0 (no) Polymerisasjon-oppstartningsprosess
MA24472A1 (fr) Procede
ID24830A (id) Proses untuk pengolahan laktam
NO20003080D0 (no) Polymerisasjon-oppstartningsprosess
MA24470A1 (fr) Procede
ID15862A (id) Proses
DE69811000D1 (de) System zum Herstellen von Bändern
DE69711853D1 (de) Pyridincarboxamid-derivate
FI974067A0 (fi) Process foer cellulasbehandling
BR9709960A (pt) N-(4-piridil)-tioamidas substituídas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application